As of May 2024 Yield10 Bioscience has a market cap of $1.85 Million. This makes Yield10 Bioscience the world's 8337th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $1.85 M | -35.46% |
2023 | $2.86 M | -65.27% |
2022 | $8.25 M | -65.63% |
2021 | $24.01 M | 24.64% |
2020 | $19.27 M | 200.95% |
2019 | $6.4 M | -23.05% |
2018 | $8.32 M | -45.22% |
2017 | $15.18 M | 53.12% |
2016 | $9.91 M | -76.43% |
2015 | $42.09 M | -24.35% |
2014 | $55.64 M | 27.71% |
2013 | $43.56 M | -14.19% |
2012 | $50.77 M | -67.29% |
2011 | $0.15 B | -52.58% |
2010 | $0.32 B | 11.72% |
2009 | $0.29 B | 0.31% |
2008 | $0.29 B | -36.73% |
2007 | $0.46 B | 25.66% |
2006 | $0.36 B |
On May 15th, 2024 the market cap of Yield10 Bioscience was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | $18.25 M | 886.38% | Bahamas |
NRC Health
NRC | $0.75 B | 40,622.11% | ๐บ๐ธ USA |